Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis Xenia M. HartChristoph HiemkeGerhard Gründer Review Open access 05 October 2022 Pages: 3377 - 3391
A systematic review on the use of clozapine in treatment of tardive dyskinesia and tardive dystonia in patients with psychiatric disorders Jocelyn WongTiffanie PangSherry Kit Wa Chan Review 30 September 2022 Pages: 3393 - 3420
Brain volume in chronic ketamine users — relationship to sub-threshold psychotic symptoms and relevance to schizophrenia Robert A. ChestersFiona PepperJames M. Stone Original Investigation Open access 06 July 2021 Pages: 3421 - 3429
The DRD2 Taq1A polymorphism moderates the effect of PTSD symptom severity on the left hippocampal CA3 volume: a pilot study Minlan YuanHongru ZhuWei Zhang Original Investigation Open access 04 June 2021 Pages: 3431 - 3438
Adenosine A2A receptor in schizophrenia: an in vivo brain PET imaging study Tiago Reis MarquesSridhar NatesanShitij Kapur Original Investigation Open access 26 June 2021 Pages: 3439 - 3445
Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder Marieke A. G. MartensNicola FilippiniBeata R. Godlewska Original Investigation Open access 03 September 2021 Pages: 3447 - 3460
The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world Rosalind WattsHannes KettnerLeor Roseman Original Investigation Open access 08 August 2022 Pages: 3461 - 3483
MCPIP1 alleviated alcohol-induced immune dysfunction via the MAPK/ERK signaling pathway Yanjie ShenKai ZhangZhenhua Ren Original Investigation 21 September 2022 Pages: 3485 - 3493
Food for thought: diet-induced impairments to decision-making and amelioration by N-acetylcysteine in male rats Serena BecchiJoshua HoodLaura H. Corbit Original Investigation 11 October 2022 Pages: 3495 - 3506
The relationship between executive functioning and addictive behavior: new insights from a longitudinal community study Anja KräplinMohsen JoshanlooMichael N. Smolka Original Investigation Open access 03 October 2022 Pages: 3507 - 3524
Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial Archana MishraK. H. ReetaMamta Sood Original Investigation 07 September 2022 Pages: 3525 - 3535
Correction to: Effect of add‑on alpha lipoic acid on psychopathology in patients with treatment‑resistant schizophrenia: a pilot randomized double‑blind placebo‑controlled trial Archana MishraK. H. ReetaMamta Sood Correction 14 September 2022 Pages: 3537 - 3537
EGR3 regulates opioid-related nociception and motivation in male rats Swarup MitraShruthi A. ThomasDavid M. Dietz Original Investigation 13 September 2022 Pages: 3539 - 3550
Contrasting effects of DOI and lisuride on impulsive decision-making in delay discounting task Kaili JiangXiaoyan LiuRuibin Su Original Investigation 15 September 2022 Pages: 3551 - 3565
Enhanced conditioned “liking” of novel visual cues paired with alcohol or non-alcohol beverage container images among individuals at higher risk for alcohol use disorder Roberto U. CofresíThomas M. PiaseckiTodd R. Schachtman Original Investigation 12 September 2022 Pages: 3567 - 3578
Rose Bengal inhibits β-amyloid oligomers-induced tau hyperphosphorylation via acting on Akt and CDK5 kinases Chen-Ye MouYan-Fei XieWei Cui Original Investigation 12 October 2022 Pages: 3579 - 3593
Signal in the noise: Altered brain activation among adolescent alcohol users detected via the analysis of intra-individual variability1 Lance O. BauerVictor M. Hesselbrock Original Investigation 14 September 2022 Pages: 3595 - 3604
Novelty-induced locomotor behavior predicts heroin addiction vulnerability in male, but not female, rats Brittany N. KuhnNazzareno CannellaPeter W. Kalivas Original Investigation 16 September 2022 Pages: 3605 - 3620
Effects of isoflurane anesthesia on addictive behaviors in rats Seong Shoon YoonBong Hyo LeeChae Ha Yang Original Investigation 15 September 2022 Pages: 3621 - 3632
Behavioral and neurochemical interactions of the tricyclic antidepressant drug desipramine with L-DOPA in 6-OHDA-lesioned rats. Implications for motor and psychiatric functions in Parkinson’s disease Kinga KamińskaTomasz LendaElżbieta Lorenc-Koci Original Investigation Open access 30 September 2022 Pages: 3633 - 3656
Detection of the role of intestinal flora and tryptophan metabolism involved in antidepressant-like actions of crocetin based on a multi-omics approach Susu LinQiaoqiao LiPing Wang Original Investigation 28 September 2022 Pages: 3657 - 3677
The nucleus accumbens dopamine increase, typically triggered by sexual stimuli in male rats, is no longer produced when animals are sexually inhibited due to sexual satiety Ana Canseco-AlbaUlises CoffeenGabriela Rodríguez-Manzo Original Investigation 03 October 2022 Pages: 3679 - 3695
Duration- and sex-dependent neural circuit control of voluntary physical activity Margaret K. TannerJazmyne K. P. DavisBenjamin N. Greenwood Original Investigation 04 October 2022 Pages: 3697 - 3709
Differences in attentional bias to smoking-related, affective, and sensation-seeking cues between smokers and non-smokers: an eye-tracking study Noreen RahmaniJonathan ChungLaurie Zawertailo Original Investigation 01 October 2022 Pages: 3711 - 3721
Reinforcing effects of phenethylamine analogs found in dietary supplements Shelby A. McGriffMichael R. ChojnackiCharles W. Schindler Original Investigation 03 October 2022 Pages: 3723 - 3730
Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis Nadia R. P. W. HuttenT. R. ArkellJ. G. Ramaekers Original Investigation Open access 13 October 2022 Pages: 3731 - 3741
